Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11056941 | 0.79 | ESR1 (0.34) | ESR1ESR2TDP1SIGMAR1TAAR1 | |
| SCHEMBL13766348 | 0.78 | ESR1 (0.37) | ESR1ESR2ALOX5TDP1SIGMAR1 | |
| SCHEMBL17948477 | 0.78 | TAAR1 (0.39) | ESR1ESR2ALOX5TDP1SIGMAR1 | |
| SCHEMBL9242232 | 0.74 | LMNA (0.44) | ESR1ESR2ALOX5ALDH1A1SIGMAR1 | |
| SCHEMBL8611174 | 0.74 | TAAR1 (0.38) | ESR1ESR2ALOX5TDP1ALDH1A1 | |
| SCHEMBL23364945 | 0.74 | ESR1 (0.34) | ESR1ESR2ALOX5TDP1SIGMAR1 | |
| SCHEMBL23364913 | 0.74 | ESR1 (0.34) | ESR1ESR2ALOX5TDP1SIGMAR1 | |
| SCHEMBL7654631 | 0.73 | LMNA (0.37) | ESR1ESR2 | |
| Biphenyl SCHEMBL11779724 | 0.71 | ALDH1A1 (0.60) | TDP1ALDH1A1PTGS2TAAR1SLC6A4 | |
| SCHEMBL7655480 | 0.70 | AOC3 (0.34) | ALDH1A1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590246-B2 | Precursor chemistry for quantum dot synthesis enabling temperature-independent modulation of reactivity | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2026-03-31 | — | — | US | disclosed |
| US-20230109627-A1 | PRECURSOR CHEMISTRY FOR QUANTUM DOT SYNTHESIS ENABLING TEMPERATURE-INDEPENDENT MODULATION OF REACTIVITY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-04-06 | — | — | US | disclosed |
| WO-2021097217-A1 | PRECURSOR CHEMISTRY FOR QUANTUM DOT SYNTHESIS ENABLING TEMPERATURE-INDEPENDENT MODULATION OF REACTIVITY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590246-B2 | Precursor chemistry for quantum dot synthesis enabling temperature-independent modulation of reactivity | TBCD, TBL2, TYR | ESR1 3689/4885ESR2 2089/4885ALOX5 4484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.